Advanced glycation end products, a potential link between psoriasis and cardiovascular disease: A case–control study | Zendy

Andaç Salman | Zendy; Tülin Ergun | Zendy; Vildan Yazici | Zendy; Di̇lek Gogas Yavuz | Zendy; Dilek Seckin-Gencosmanoglu | Zendy; G. Özen | Zendy; Haner Di̇reskeneli̇ | Zendy; Nevsun İnanç | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Advanced glycation end products, a potential link between psoriasis and cardiovascular disease: A case–control study

Author(s) -

Andaç Salman,

Tülin Ergun,

Vildan Yazici,

Di̇lek Gogas Yavuz,

Dilek Seckin-Gencosmanoglu,

G. Özen,

Haner Di̇reskeneli̇,

Nevsun İnanç

Publication year - 2019

Publication title -

indian journal of dermatology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.395

H-Index - 36

eISSN - 1998-3611

pISSN - 0019-5154

DOI - 10.4103/ijd.ijd_396_18

Subject(s) - medicine , psoriasis , glycation , inflammation , context (archaeology) , mann–whitney u test , disease , gastroenterology , premature aging , systemic inflammation , diabetes mellitus , cardiology , endocrinology , dermatology , physiology , paleontology , biology

Advanced glycation end products (AGEs) promote oxidative stress and inflammation by altering structure and function of proteins. They are excessively produced mainly in hyperglycemia, chronic inflammation and are involved in the development of atherosclerosis and cardiovascular disease.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research